Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Selling Inovalon Holdings Inc (INOV)

Page 1 of 2

It’s a little-known fact that stock performance is not evenly distributed (i.e. you don’t have a 50/50 chance of picking a market-beating stock). In fact, despite the S&P 500 gaining about 5.2% between November 1, 2014 and October 30, 2015, less than 49% of the stocks in the index beat the market during that time. In contrast, the 30 stocks from the index which were the most popular among the investors that we track returned 9.5% during that time and 63% of them beat the market. This shows that while hedge funds get a lot of flak from the mainstream media for their performance, it can be rewarding to follow their moves using the right sets of data. Even then, there is never a fool proof strategy to generating returns, as even the collective wisdom of top hedge funds gets it wrong some times, as in the case of some of their top picks from the index like Micron and Anadarko. The data though, shows that following the collective wisdom of select hedge funds can be a very wise move overall.

Is Inovalon Holdings Inc (NASDAQ:INOV) worth your attention right now? The best stock pickers are in a bearish mood, and for the right reasons, as the shares of the company lost 25.34% value during the third quarter. The number of bullish hedge fund positions fell by 1 lately. Our team decided to uncover hedge funds that held stake in Inovalon Holdings Inc (NASDAQ:INOV), at the end of September.

The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Royal Gold, Inc USA) (NASDAQ:RGLD), WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX), and MPLX LP (NYSE:MPLX) to gather more data points.

Follow Inovalon Holdings Inc. (NASDAQ:INOV)
Trade (NASDAQ:INOV) Now!

According to most market participants, hedge funds are seen as underperforming, old financial tools of the past. While there are over 8000 funds in operation today, We choose to focus on the crème de la crème of this club, about 700 funds. It is estimated that this group of investors manages the lion’s share of the smart money’s total asset base, and by shadowing their highest performing equity investments, Insider Monkey has discovered many investment strategies that have historically outperformed Mr. Market. Insider Monkey’s small-cap hedge fund strategy outpaced the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

With all of this in mind, we’re going to take a peek at the fresh action encompassing Inovalon Holdings Inc (NASDAQ:INOV).

What does the smart money think about Inovalon Holdings Inc (NASDAQ:INOV)?

Heading into Q4, a total of 6 of the hedge funds tracked by Insider Monkey held long positions in this stock, a decline of 14% from the previous quarter. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were boosting their holdings significantly (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Rock Springs Capital Management, managed by Kris Jenner, Gordon Bussard, Graham McPhail, holds the most valuable position in Inovalon Holdings Inc (NASDAQ:INOV). Rock Springs Capital Management has a $14.3 million position in the stock, comprising 1.2% of its 13F portfolio. The second most bullish fund manager is Morris Mark of Mark Asset Management, with a $4.8 million position; the fund has 1.4% of its 13F portfolio invested in the stock. Remaining peers that hold long positions encompass Ian P. Murray’s Lanexa Global Management, Israel Englander’s Millennium Management, and Ken Griffin’s Citadel Investment Group.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!